Its well documented that many people whose serum B12 is between 200pg/ml and 350pg/ml have a vitamin B12 deficiency
[oai_citation:0PMC]( Key pointMost findings below come from in vitro or non-human in vivo experiments
Typical ranges: BPC-157 at 250 to 750 mcg/day, semaglutide at 0.25 to 2.4 mg/week, CJC-1295 at 100 to 200 mcg per injection, and TB-500 at 2 to 5 mg twice weekly
It is longer-lasting, more stable and more effective than synthetic alternatives
Some protocols combine approaches, using local injection near primary wounds with periodic systemic dosing for comprehensive support
FIGURE 2 Finally, BPC 157 administration cured the alkali burn-induced skin injury ( in vitro ( Finally, this effect is apparently not species specific, and it was seen in the bigger animals as well